“My ultimate hope is that we improve pre-clinical testing for potential therapies and drugs to the point where it accelerates the pipeline of discovery, so that if someone finds a new drug or a new therapy, we can test it really quickly in a model that correctly reflects the biology of the human and get that in patients more quickly, and hopefully with better outcomes,” Dr Mason said.